[Experimental findings and new aspects in extrapyramidal diseases].
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001833:Body Temperature Regulation / Q000187:drug effects; D002819:Chorea / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009069:Movement Disorders / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D010300:Parkinson Disease / Q000378:metabolism; D010546:Perphenazine / Q000494:pharmacology; D010649:Phenylalanine / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism*; D014443:Tyrosine / Q000494:pharmacology
D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D014443:Tyrosine; D010649:Phenylalanine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D006916:5-Hydroxytryptophan; D010546:Perphenazine; D004298:Dopamine; D009638:Norepinephrine
Experimentelle Befunde und neue Aspekte bei extrapyramidalen Erkrankungen.